SCHEMBL4886697

SCHEMBL4886697

CCc1nc(N)c(C(=O)OC(C)(C)C)n1Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
TLR7 Q9NYK1 4/20 0.46
KDM4E B2RXH2 4/20 0.44
ALDH1A1 P00352 4/20 0.44
GAA P10253 4/20 0.44
HPGD P15428 4/20 0.44
TSHR P16473 2/20 0.44
CASP1 P29466 2/20 0.44
CASP7 P55210 2/20 0.44
HSD17B10 Q99714 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAPT P10636 4/20 0.40
GLA P06280 3/20 0.40
HIF1A Q16665 2/20 0.39
THRB P10828 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895350 0.85 ALDH1A1 (0.54) TLR7KDM4EALDH1A1GAAHPGD
SCHEMBL4884454 0.82 CRHBP (0.43) CRHBPCRHR2TLR7KDM4EALDH1A1
SCHEMBL4890027 0.78 ADORA3 (0.43) CRHBPCRHR2TLR7ALDH1A1HPGD
SCHEMBL4740271 0.73 MEN1 (0.52) CRHBPCRHR2TLR7KDM4EALDH1A1
SCHEMBL7878433 0.73 CYP19A1 (0.54) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL29779736 0.72 CRHBP (0.47) CRHBPCRHR2KDM4EALDH1A1GAA
SCHEMBL4859820 0.71 MAPK1 (0.42) ALDH1A1TSHRCASP1CASP7HSD17B10
SCHEMBL7312358 0.71 AGTR1 (0.56)
SCHEMBL28811878 0.69 CYP1A2 (0.45) CRHBPCRHR2KDM4EALDH1A1MAPT
SCHEMBL3498181 0.69 AR (0.53) TLR7KDM4EALDH1A1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312305-A1 Imidazoles as Gaba- B Receptor Modulators ASTRAZENECA AB (SE) 2008-12-18 US claimed
US-20080312305-A1 Imidazoles as Gaba- B Receptor Modulators ASTRAZENECA AB (SE) 2008-12-18 US disclosed
US-20080312305-A1 Imidazoles as Gaba- B Receptor Modulators ASTRAZENECA AB (SE) 2008-12-18 US disclosed
US-20080312305-A1 Imidazoles as Gaba- B Receptor Modulators ASTRAZENECA AB (SE) 2008-12-18 US disclosed
WO-2007073299-A1 IMIDAZOLES AS GABA-B RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2007-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312305-A1 Imidazoles as Gaba- B Receptor Modulators GABRB1, GABBR2, GABRB2 CRHBP 1128/4885CRHR2 192/4885TLR7 1832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.